Topic infliximab injection for refractory rectal stenosis in Crohn’s disease: long-term follow-up in two patients

Topic infliximab injection for refractory rectal stenosis in Crohn’s disease: long-term... Int J Colorectal Dis (2017) 32:1289–1294 DOI 10.1007/s00384-017-2860-2 ORIGINAL ARTICLE Topic infliximab injection for refractory rectal stenosis in Crohn’s disease: long-term follow-up in two patients 1,2 2 2 Niels Teich & Ingo Wallstabe & Ingolf Schiefke Accepted: 7 July 2017 /Published online: 19 July 2017 Springer-Verlag GmbH Germany 2017 . . . Abstract Keywords Infliximab Crohn’s disease Rectal stenosis Purpose TNF blockers are approved for intravenous or sub- Endoscopic balloon dilation cutaneous systemic therapy of many chronic inflammatory diseases. As it is not possible to achieve a sufficient local clinical improvement through systemic therapy in every pa- Introduction tient, diverse approaches of topical therapy using TNF blockers have been investigated in recent years. Crohn’s disease (CD) usually starts with an inflammatory dis- Methods In this paper, we report on long-term clinical results ease phenotype in the early phase and frequently progresses of originator infliximab (IFX) injections into symptomatic com- into fibrostenotic complications. Ten years after diagnosis, bined scarring and inflammatory stenoses of the rectum in two more than 50% of CD patient populations develop stricturing patients with Crohn’s disease. Aiming at high tissue IFX levels, or penetrating disease [1, 2]. After 20 years of disease, approx- 25 mg of http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png International Journal of Colorectal Disease Springer Journals

Topic infliximab injection for refractory rectal stenosis in Crohn’s disease: long-term follow-up in two patients

Loading next page...
 
/lp/springer_journal/topic-infliximab-injection-for-refractory-rectal-stenosis-in-crohn-s-ZoZmeo4Ppp
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag GmbH Germany
Subject
Medicine & Public Health; Surgery; Internal Medicine; Gastroenterology; Hepatology; Proctology
ISSN
0179-1958
eISSN
1432-1262
D.O.I.
10.1007/s00384-017-2860-2
Publisher site
See Article on Publisher Site

Abstract

Int J Colorectal Dis (2017) 32:1289–1294 DOI 10.1007/s00384-017-2860-2 ORIGINAL ARTICLE Topic infliximab injection for refractory rectal stenosis in Crohn’s disease: long-term follow-up in two patients 1,2 2 2 Niels Teich & Ingo Wallstabe & Ingolf Schiefke Accepted: 7 July 2017 /Published online: 19 July 2017 Springer-Verlag GmbH Germany 2017 . . . Abstract Keywords Infliximab Crohn’s disease Rectal stenosis Purpose TNF blockers are approved for intravenous or sub- Endoscopic balloon dilation cutaneous systemic therapy of many chronic inflammatory diseases. As it is not possible to achieve a sufficient local clinical improvement through systemic therapy in every pa- Introduction tient, diverse approaches of topical therapy using TNF blockers have been investigated in recent years. Crohn’s disease (CD) usually starts with an inflammatory dis- Methods In this paper, we report on long-term clinical results ease phenotype in the early phase and frequently progresses of originator infliximab (IFX) injections into symptomatic com- into fibrostenotic complications. Ten years after diagnosis, bined scarring and inflammatory stenoses of the rectum in two more than 50% of CD patient populations develop stricturing patients with Crohn’s disease. Aiming at high tissue IFX levels, or penetrating disease [1, 2]. After 20 years of disease, approx- 25 mg of

Journal

International Journal of Colorectal DiseaseSpringer Journals

Published: Jul 19, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off